ETLI:F:F-Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 8.988

Change

0.00 (0.00)%

Market Cap

USD 0.02B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-15 )

ETFs Containing ETLI:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.10% 16% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.10% 14% F 35% F
Trailing 12 Months  
Capital Gain -14.12% 12% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -14.12% 10% F 32% F
Trailing 5 Years  
Capital Gain 4.90% 36% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.90% 36% F 35% F
Average Annual (5 Year Horizon)  
Capital Gain 1.52% 47% F 52% F
Dividend Return 1.52% 45% F 47% F
Total Return N/A 32% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) 12.63% 52% F 78% C+
Risk Adjusted Return 12.01% 42% F 48% F
Market Capitalization 0.02B 7% C- 16% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.